SCHEMBL30336296

SCHEMBL30336296

CC1CCN(c2ccc(Nc3ccc4c(c3)n(C)c(=O)n4C)cn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
BCL6 P41182 8/20 0.42
SMN1; SMN2 Q16637 5/20 0.40
ALDH1A1 P00352 4/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 1/20 0.40
CDK1 P06493 1/20 0.40
CDK4 P11802 1/20 0.40
CCNB1 P14635 1/20 0.40
CCND1 P24385 1/20 0.40
FLT3 P36888 1/20 0.40
NCOR2 Q9Y618 3/20 0.40
LMNA P02545 2/20 0.39
NPC1 O15118 2/20 0.39
TSHR P16473 2/20 0.39
RAB9A P51151 2/20 0.39
TRIM24 O15164 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
PKM P14618 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865632 1.00 MAPT (0.44) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865479 0.87 BCL6 (0.44) BCL6SMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL31123194 0.87 MAPT (0.51) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865775 0.87 MAPT (0.51) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL30336497 0.82 SMN1; SMN2 (0.46) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865209 0.82 SMN1; SMN2 (0.46) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL30336503 0.79 ALDH1A1 (0.48) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865509 0.79 SMN1; SMN2 (0.42) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865649 0.79 ALDH1A1 (0.48) MAPTBCL6SMN1; SMN2ALDH1A1TP53
SCHEMBL24865677 0.78 SMN1; SMN2 (0.41) BCL6SMN1; SMN2ALDH1A1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 MAPT 3110/4885BCL6 390/4885SMN1; SMN2 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.